Metastatic Soft Tissue Sarcoma Recruiting Phase 1 / 2 Trials for Pazopanib (DB06589)

Also known as: Metastatic Soft-tissue Sarcoma / Metastatic Soft-Tissue Sarcomas

IndicationStatusPhase
DBCOND0055864 (Metastatic Soft Tissue Sarcoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05180695HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue SarcomasTreatment
NCT03660930Nanoparticle Albumin-Bound Rapamycin and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue SarcomasTreatment